The trajectory of Viagra, initially marketed by copyright, presents a fascinating case study for stakeholders considering the drug sector. While its initial success and creation of billions in earnings , the intellectual property lapse has opened the floodgates for competing medications, significantly diminishing profit potential . This change rais